Los Angeles Times
Shares of Amgen rose 5 cents to $59.89 in after-hours trading after falling $1.01 to close at $59.84 during the lawful trading session.
and more »
Monday, August 17, 2009
Amgen said Vectibix improved survival as second-line treatment for ... - Los Angeles Times
Los Angeles Times
Shares of Amgen rose 5 cents to $59.89 in after-hours trading after falling $1.01 to close at $59.84 during the lawful trading session.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment